MARKET

GDRX

GDRX

Goodrx Holdings, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

6.96
+0.25
+3.73%
After Hours: 7.10 +0.14 +2.01% 17:38 06/24 EDT
OPEN
6.85
PREV CLOSE
6.71
HIGH
7.10
LOW
6.71
VOLUME
2.17M
TURNOVER
0
52 WEEK HIGH
48.05
52 WEEK LOW
5.62
MARKET CAP
2.76B
P/E (TTM)
-183.6412
1D
5D
1M
3M
1Y
5Y
Expert Ratings for GoodRx Holdings
Analysts have provided the following ratings for GoodRx Holdings (NASDAQ:GDRX) within the last quarter:
Benzinga · 3d ago
Baird Maintains Neutral Rating for GoodRx Holdings: Here's What You Need To Know
Baird has decided to maintain its Neutral rating of GoodRx Holdings (NASDAQ:GDRX) and lower its price target from $7.00 to $6.00. Shares of GoodRx Holdings are trading up 6.94% over the last 24 hours, at $6.32 per share. A move to $6.00 would account for a...
Benzinga · 3d ago
Baird Adjusts Price Target on GoodRx Holdings to $6 From $7, Maintains Neutral Rating
MT Newswires · 3d ago
CRTX, GDRX, RYTM and KMPH among after hour movers
Gainers: Cortexyme (CRTX) +7.9%. GoodRx Holdings (GDRX) +5.4%. Concert Pharmaceuticals (CNCE) +4.9%. Roku (ROKU) +4.3%. Mercer International (MERC) +4.3%. Losers: Rhythm Pharmaceuticals (RYTM) -8.5%. Redbox Entertainment (RDBX) -3.6%. KemPharm (KMPH) -3.1%...
Seekingalpha · 06/16 21:36
ARWR, GDRX and ESPR among after hour movers.
Gainers: Inari Medical (NARI) +6%. Rhythm Pharmaceuticals (RYTM) +5%. Adaptive Biotechnologies (ADPT) +5%. The RealReal (REAL) +5%. Esperion Therapeutics (ESPR) +4%. Losers: GoodRx Holdings (GDRX) -6%. AlloVir (ALVR) -5%. Caribou Biosciences (CRBU)
Seekingalpha · 06/15 21:24
Cowen Adjusts GoodRx Holdings' Price Target to $9 From $22, Keeps Market Perform Rating
MT Newswires · 06/13 08:51
91 Biggest Movers From Friday
Gainers RISE Education Cayman Ltd (NYSE: REDU) shares jumped 138.5% to settle at $3.41 on Friday. RISE Education announced expected timing for the completion of the merger with Dada Auto.
Benzinga · 06/13 08:28
GoodRx downgraded to neutral at Goldman Sachs amid uncertainty on consumer demand
Goldman Sachs has downgraded GoodRx (NASDAQ:GDRX) to neutral from buy due to lower valuation multiples. The firm also cut the target price to $9 from $12 (~33% upside based on
Seekingalpha · 06/10 16:55
More
No Data
Learn about the latest financial forecast of GDRX. Analyze the recent business situations of Goodrx Holdings, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 19 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

15.79%Strong Buy
5.26%Buy
73.68%Hold
5.26%Under-perform
0.00%Sell
Analyst Price Target
The average GDRX stock price target is 10.90 with a high estimate of 17.40 and a low estimate of 6.00.
High17.40
Average10.90
Low6.00
Current 6.96
EPS
Actual
Estimate
0.030.050.070.10
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 179
Institutional Holdings: 194.97M
% Owned: 49.18%
Shares Outstanding: 396.46M
TypeInstitutionsShares
Increased
54
15.19M
New
28
4.39M
Decreased
45
8.08M
Sold Out
74
21.52M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
No Data
No Data
No Data
About GDRX
GoodRx Holdings, Inc. is a consumer-focused digital healthcare platform. The Company provides GoodRx platform, which aggregates and analyzes pricing data from a range of different sources. The platform provides access to medication savings programs, medical provider consultations and lab tests through its telehealth offerings, GoodRx Care and the GoodRx Telehealth Marketplace, and other healthcare related content. Its prescription offering provides price comparisons and negotiated prices on prescriptions. Its subscription offerings provide consumers and their families with access to lower prescription prices on select medications in select pharmacies for a monthly or annual subscription fee. Its pharma manufacturers provide affordability solutions such as co-pay cards, patient assistance programs, care portals and other savings options. Its prescription transactions offering provides curated, geographically relevant price comparisons and negotiated prices on prescriptions

Webull offers kinds of Goodrx Holdings Inc stock information, including NASDAQ:GDRX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, GDRX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading GDRX stock methods without spending real money on the virtual paper trading platform.